A. Capron, F. Musuamba, D. Latinne, M. Mourad, J. Lerut et al., Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells, Ther. Drug Monit, pp.31-178, 2009.

F. Lemaitre, M. Antignac, and C. Fernandez, Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: Application to cardiac transplant recipients, Clin. Biochem, vol.46, pp.1538-1541, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01068718

D. Pensi, A. De-nicolò, M. Pinon, P. L. Calvo, A. Nonnato et al., An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells, J. Pharm. Biomed. Anal, pp.107-512, 2015.

A. Capron, M. Mourad, D. Meyer, M. De-pauw, L. Eddour et al., CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation, Pharmacogenomics, pp.11-703, 2010.

L. Elens, A. Capron, V. V. Kerckhove, J. Lerut, M. Mourad et al., A and Accepted Article, 1199.

, T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation, vol.17, pp.873-883, 2007.

G. Dessilly, L. Elens, N. Panin, A. Capron, A. Decottignies et al., ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines, PloS One, vol.9, p.91555, 2014.

C. Giraud, S. Manceau, and J. Treluyer, ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies, Expert. Opin. Drug Metab. Toxicol, pp.6-571, 2010.

M. Fukudo, I. Yano, T. Katsura, N. Ito, S. Yamamoto et al., A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection, Drug Metab. Pharmacokinet, pp.25-411, 2010.

M. Roussel, C. Benard, B. Ly-sunnaram, and T. Fest, Refining the white blood cell differential: the first flow cytometry routine application, Cytom. Part. J. Int. Soc. Anal. Cytol, pp.77-552, 2010.

B. Blanchet, A. Hulin, C. Duvoux, and A. Astier, Determination of serine/threonine protein phosphatase type 2B (PP2B) in lymphocytes by HPLC, Anal. Biochem, pp.312-313, 2003.

F. Lemaitre, B. Blanchet, M. Latournerie, M. Antignac, P. Houssel-debry et al., Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells, Clin. Biochem, pp.48-406, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01103437

A. Capron, J. Lerut, D. Latinne, J. Rahier, V. Haufroid et al., Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study: PBMCs tacrolimus levels and graft rejection, Transpl. Int, vol.25, pp.41-47, 2012.

U. Christians, T. Strom, Y. L. Zhang, W. Steudel, V. Schmitz et al., Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics, Ther. Drug Monit, vol.28, pp.39-44, 2006.

K. M. Giacomini and S. Huang, Transporters in drug development and clinical pharmacology, Clin. Pharmacol. Ther, pp.94-97, 2013.

C. E. Staatz and S. E. Tett, Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation, Clin. Pharmacokinet, pp.43-623, 2004.

O. Janneh, A. Owen, B. Chandler, R. C. Hartkoorn, C. A. Hart et al., Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP, Aids, pp.19-2097, 2005.

M. Kakumoto, T. Sakaeda, K. Takara, T. Nakamura, T. Kita et al., Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil, Cancer Sci, vol.94, pp.81-86, 2003.

E. Jouan, L. Vée, M. Mayati, A. Denizot, C. Parmentier et al., Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay, Pharmaceutics, p.8, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01305488

A. Bruyere, C. Hubert, L. Vee, M. Chedik, L. Sayyed et al., Inhibition of SLC drug transporter activities by environmental bisphenols, Toxicol. Vitro Int. J. Publ. Assoc. BIBRA, p.40, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01467545

N. Shuker, R. Bouamar, W. Weimar, R. H. Van-schaik, T. Van-gelder et al., ATPbinding cassette transporters as pharmacogenetic biomarkers for kidney transplantation, Clin. Chim. Acta Int. J. Clin. Chem, pp.413-1326, 2012.

O. Janneh, R. C. Hartkoorn, E. Jones, A. Owen, S. A. Ward et al., Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir, Br. J. Pharmacol, pp.155-875, 2008.

F. Sommer, S. Bischof, M. Röllinghoff, and M. Lohoff, Demonstration of organic anion transport in T lymphocytes. L-lactate and fluo-3 are target molecules, J. Immunol. Baltim. Md, vol.153, pp.3523-3532, 1994.

A. Boivin, H. Cardinal, A. Barama, J. Naud, V. Pichette et al., Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients, Drug Metab. Pharmacokinet, pp.28-274, 2013.

A. Kalliokoski and M. Niemi, Impact of OATP transporters on pharmacokinetics, Br. J. Pharmacol, pp.158-693, 2009.

K. Maeda, Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs, Biol. Pharm. Bull, pp.38-155, 2015.

M. Roth, A. Obaidat, B. Hagenbuch, and . Oatps, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies, Br. J. Pharmacol, vol.165, pp.1260-1287, 2012.

H. S. Kim, Y. D. Min, and C. H. Choi, Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid, Biochem. Biophys. Res. Commun, pp.283-64, 2001.

S. Gollapudi, C. H. Kim, B. N. Tran, S. Sangha, and S. Gupta, Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in Pglycoprotein-overexpressing HL60/Tax and P388/ADR cells, Cancer Chemother. Pharmacol, vol.40, pp.150-158, 1997.

C. Damon, M. Luck, L. Toullec, I. Etienne, M. Buchler et al., Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening, Am. J. Transplant, pp.17-1008, 2017.

E. S. Kang, M. S. Kim, Y. S. Kim, C. H. Kim, S. J. Han et al., A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients, Diabetes, pp.57-1043, 2008.

K. Sugano, M. Kansy, P. Artursson, A. Avdeef, S. Bendels et al., Coexistence of passive and carrier-mediated processes in drug transport, Nat. Rev. Drug Discov, pp.9-597, 2010.

R. Vafadari, R. Bouamar, D. A. Hesselink, R. Kraaijeveld, R. H. Van-schaik et al., Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus, Ther. Drug Monit, pp.35-459, 2013.

F. Lemaitre, M. Antignac, M. Verdier, E. Bellissant, and C. Fernandez, Opportunity to monitor Accepted Article immunosuppressive drugs in peripheral blood mononuclear cells: Where are we and where are we going?, Pharmacol. Res, pp.74-109, 2013.

A. Capron, V. Haufroid, and P. Wallemacq, Intra-cellular immunosuppressive drugs monitoring: A step forward towards better therapeutic efficacy after organ transplantation?, Pharmacol. Res, vol.111, pp.610-618, 2016.

M. Brunet, M. Shipkova, T. Van-gelder, E. Wieland, C. Sommerer et al., Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation, Ther. Drug Monit, pp.38-39, 2016.

S. Sanquer, C. Amrein, D. Grenet, R. Guillemain, B. Philippe et al., Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up, PLoS ONE, vol.8, p.59634, 2013.

B. Blanchet, C. Duvoux, C. E. Costentin, C. Barrault, B. Ghaleh et al., Pharmacokineticpharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early posttransplantation period, Ther. Drug Monit, vol.30, pp.412-418, 2008.

R. J. Bram, D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree, Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location, Mol. Cell Biol, vol.13, pp.4760-4760, 1993.

L. Kung and P. F. Halloran, Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations, Transplantation, pp.70-327, 2000.

L. Kung, T. D. Batiuk, S. Palomo-pinon, J. Noujaim, L. M. Helms et al., Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine, Am. J. Transplant, vol.1, pp.325-333, 2001.

M. Fukudo, I. Yano, S. Masuda, S. Fukatsu, T. Katsura et al., Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients, Clin. Pharmacol. Ther, vol.78, pp.168-181, 2005.